English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/174734
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

Title

Interactomics and tick vaccine development: new directions for the control of tick-borne diseases

AuthorsArtigas-Jerónimo, Sara; Fuente, José de la ; Villar, Margarita
KeywordsTick
Interactomics
Tick-borne diseases
Vaccine
Issue Date2018
PublisherTaylor & Francis
CitationExpert Review of Proteomics 15(8): 627-635 (2018)
Abstract[Introduction]: Ticks are obligate hematophagous arthropod ectoparasites that transmit pathogens responsible for a growing number of tick-borne diseases (TBDs) throughout the world. Vaccines have been shown to be the most efficient, cost-effective, and environmentally friendly approach for the control of ticks and the prevention of TBDs. Although at its infancy, interactomics has shown the possibilities that the knowledge of the interactome offers in understanding tick biology and the molecular mechanisms involved in pathogen infection and transmission. Furthermore, interactomics has provided information for the identification of candidate vaccine protective antigens. [Areas covered]: In this special report, we review the different approaches used for the study of protein–protein physical and functional interactions, and summarize the application of interactomics to the characterization of tick biology and tick–host–pathogen interactions, and the possibilities that offers to vaccine development for the control of ticks and TBDs. [Expert commentary]: The combination of interacting proteins in antigen formulations may increase vaccine efficacy. In the near future, the combination of interactomics with other omics approaches such as transcriptomics, proteomics, metabolomics, and regulomics together with intelligent Big Data analytic techniques will improve the high throughput discovery and characterization of vaccine protective antigens for the prevention and control of TBDs.
URIhttp://hdl.handle.net/10261/174734
Identifiersdoi: 10.1080/14789450.2018.1506701
e-issn: 1744-8387
issn: 1478-9450
Appears in Collections:(IREC) Artículos
Files in This Item:
File Description SizeFormat 
accesoRestringido.pdf15,38 kBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.